Form 8-K - Current report:
SEC Accession No. 0001493152-24-046544
Filing Date
2024-11-18
Accepted
2024-11-18 16:44:01
Documents
15
Period of Report
2024-11-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36203
2 ex3-1.htm EX-3.1 8073
  Complete submission text file 0001493152-24-046544.txt   221165

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE ghsi-20241114.xsd EX-101.SCH 3033
4 XBRL LABEL FILE ghsi-20241114_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE ghsi-20241114_pre.xml EX-101.PRE 24177
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3591
Mailing Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098
Business Address 2925 RICHMOND AVENUE SUITE 1200 HOUSTON TX 77098 (800) 873-5141
Guardion Health Sciences, Inc. (Filer) CIK: 0001642375 (see all company filings)

EIN.: 474428421 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38861 | Film No.: 241472063
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)